Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Laurence Lesueur"'
Autor:
Dennis Bigg, José Camara, Laurence Lesueur-Ginot, Hélène Coulomb, Philip G. Kasprzyk, Danièle Demarquay, Marion Huchet, Olivier Lavergne, Gregoire Prevost
Publikováno v:
Cancer Research. 64:4942-4949
BN80927 belongs to a novel family of camptothecin analogs, the homocamptothecins, developed on the concept of topoisomerase I (Topo I) inhibition and characterized by a stable seven-membered β-hydroxylactone ring. Preclinical data reported here show
Autor:
José Camara, Laurence Lesueur-Ginot, Christian Bailly, Hélène Coulomb, Marion Huchet, Danièle Demarquay, Dennis Bigg, Olivier Lavergne, Philip G. Kasprzyk
Publikováno v:
Anti-Cancer Drugs. 12:9-19
BN 80915, a lead compound of the homocamptothecin (hCPT) family, has entered clinical trials. BN 80915 is a difluoro-hCPT where the six-membered a-hydroxylactone ring of camptothecin (CPT) is replaced by a seven-membered b-hydroxylactone ring. Precli
Autor:
Olivier Lavergne, Alain Rolland, Christophe Lanco, Laurence Lesueur-Ginot, Marion Huchet, Dennis Bigg, Danièle Demarquay, Hélène Coulomb, Jeremiah Harnett
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 9:2599-2602
BN 80927, a novel homocamptothecin derivative, inhibits both topoisomerase I and topoisomerase II mediated DNA relaxation and shows pronounced cytotoxicity against HT29, SKOV-3, DU145 and MCF7 human tumor cell lines.
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 7:2235-2238
The crucial E-ring of camptothecin has been modified to afford the homologous β-hydroxylactone derivative BN 80245. This compound, which is more stable than camptothecin, remains a potent inhibitor of both cell growth and topoisomerase I.
Autor:
François Schächter, Philippe Froguel, Laurence Faure-Delanef, Laurence Lesueur-Ginot, Hervé Rouger, Daniel Cohen, Frédérique Guénot
Publikováno v:
Nature Genetics. 6:29-32
In an effort to dissect the genetic components of longevity, we have undertaken case-control studies of populations of centenarians (n = 338) and adults aged 20-70 years at several polymorphic candidate gene loci. Here we report results on two genes,
Publikováno v:
ChemInform. 28
Autor:
Alain Rolland, Christophe Lanco, Olivier Lavergne, Marion Huchet, Hélène Coulomb, Dennis Bigg, Laurence Lesueur-Ginot, Danièle Demarquay, Jeremiah Harnett
Publikováno v:
ChemInform. 30
BN 80927, a novel homocamptothecin derivative, inhibits both topoisomerase I and topoisomerase II mediated DNA relaxation and shows pronounced cytotoxicity against HT29, SKOV-3, DU145 and MCF7 human tumor cell lines.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 1991, 88 (3), pp.824-828
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 1991, 88 (3), pp.824-828
The biological activities of long and short forms of the prolactin receptor have been compared. These two receptors expressed in mammalian cells were shown to bind prolactin with equal high affinity. The ability of these different forms to transduce
Autor:
Laurence, Lesueur, Jean-Louis, Arne
Publikováno v:
La Revue du praticien. 57(18)
Autor:
Danièle, Demarquay, Marion, Huchet, Helène, Coulomb, Laurence, Lesueur-Ginot, Olivier, Lavergne, José, Camara, Philip G, Kasprzyk, Grégoire, Prévost, Dennis C H, Bigg
Publikováno v:
Cancer research. 64(14)
BN80927 belongs to a novel family of camptothecin analogs, the homocamptothecins, developed on the concept of topoisomerase I (Topo I) inhibition and characterized by a stable seven-membered beta-hydroxylactone ring. Preclinical data reported here sh